Greenbrook TMS Reports Fiscal 2022 Operational and Financial Results

TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its fourth quarter 2022 (“Q4 2022”) and year-end 2022 (“Fiscal 2022”) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated. FISCAL 2022 OPERATIONAL AND FINANCIAL HIGHLIGHTS Fiscal 2022 revenue increased by 32% to $69.1 … [Read more…]

BeautyHealth’s Hydrafacial Opens New Beijing Experience Center, Signaling Continued Investment in High-Growth China Market

LONG BEACH, Calif.–(BUSINESS WIRE)–The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the opening of the Hydrafacial Experience Center in Beijing. The Experience Center, Hydrafacial’s second location in China after Shanghai, will act as a flagship training facility for estheticians and a showroom to host influencers, editors and special events. Located … [Read more…]

Boomerang Medical Announces First Patients Enrolled in Multi-Center Clinical Trial Evaluating Breakthrough Bioelectronic Device for Inflammatory Bowel Disease

Kansas Gastroenterology, LLC and Columbia University Irving Medical Center Enroll First Patients in Nation in Clinical Trial of Boomerang Medical’s Nerve Stimulation Device for Crohn’s Disease and Ulcerative Colitis MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Boomerang Medical, a women-led bioelectronic medicine company, has announced the enrollment of the first patients in its U.S. clinical trial evaluating the use … [Read more…]

NSF Names Jose Luis Borrero Chief Financial Officer

Global Public Health Organization Announces Update to C-Suite ANN ARBOR, Mich.–(BUSINESS WIRE)–NSF, a leading global public health and safety organization, today named Jose Luis Borrero its Chief Financial Officer. Borrero brings strong financial and operational leadership experience to his new role, where he will lead NSF’s global finance organization and oversee its numerous financial activities. … [Read more…]

Sulbactam-Durlobactam Unanimously Recommended for Approval by FDA Advisory Committee

New Drug Application (NDA) for sulbactam-durlobactam for the treatment of adults with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex (Acinetobacter), is currently under Priority Review by the FDA with a PDUFA target action date of May 29, 2023 BURLINGAME, Calif.–(BUSINESS WIRE)–Innoviva, Inc. (Nasdaq: INVA) (Innoviva), a diversified … [Read more…]

Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023

PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first quarter of 2023 on Thursday, May 4, 2023, at 6:30 a.m. (ET). Conference call and webcast: … [Read more…]

Toku Inc. Series A Preferred Investment Round Led by National Vision, Inc. and Topcon Healthcare

To commercialize Toku’s artificial intelligence platform that analyzes retinal images to detect cardiovascular disease and other potential health risks DULUTH, Ga.–(BUSINESS WIRE)–Toku Inc., a leader in applying AI-powered diagnostic and screening tools to retinal imaging, announced today the closing of its $8 million Series A Preferred financing round. The financing was co-led by National Vision, … [Read more…]

Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval

Omisirge is approved by the FDA as a new donor source for allogeneic stem cell transplant Global, randomized Phase 3 clinical trial showed faster neutrophil recovery and reduced bacterial and fungal infections as compared to standard cord blood Omisirge may increase access to stem cell transplant, including among patients from diverse backgrounds Conference call April … [Read more…]

Cross Country Healthcare to Attend the 2023 BofA Healthcare Conference

BOCA RATON, Fla.–(BUSINESS WIRE)–Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in the BofA Healthcare Conference taking place May 9–11, 2023 at the Encore Hotel in Las Vegas. John Martins, President & Chief Executive Officer, and Josh Vogel, Vice President, Investor Relations, will participate in one-on-one investor … [Read more…]

GRAIL Presents New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment at American Association for Cancer Research (AACR) Annual Meeting 2023

GRAIL’s Methylation Assay Had 92% Cancer Detection Rate Across Six Hematologic Malignancies With 96% Accuracy in Determining the Hematologic Malignancy Subtype Findings Support Use of GRAIL’s Methylation Platform to Identify Residual Disease in Post-Treatment Settings MENLO PARK, Calif. & CAMBRIDGE, England–(BUSINESS WIRE)–GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it … [Read more…]